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Nontuberculous Mycobacterial Lung Disease Caused by Mycobac-
terium chelonae: A Case Report
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Mycobacterium chelonae lung disease is very rare. We report a case of lung disease caused by M. chelonae in 
a previously healthy woman. A 69-year-old woman was referred to our hospital because of hemoptysis. A computed 
tomography (CT) scan of the chest revealed bronchiolitis associated with bronchiectasis in the lingular division 
of the left upper lobe. Nontuberculous mycobacteria were isolated three times from sputum specimens. All isolates 
were identified as M. chelonae by various molecular methods that characterized rpoB and hsp65 gene sequences. 
Although some new lesions including bronchiolitis in the superior segment of the left lower lobe developed on 
the chest CT scan 35 months after diagnosis, she has been followed up without antibiotic therapy because of 
her mild symptoms. To the best of our knowledge, this is the first case of M. chelonae lung disease in Korea 
in which the etiologic organisms were confirmed using molecular techniques.
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Introduction
  Nontuberculous mycobacteria (NTM) are generally 
classified as either slow or rapid growers. Rapidly grow-
ing mycobacteria (RGM), which are characterized by 
visible growth on solid media within 7 days, include 
three clinically relevant species, Mycobacterium fortu-
itum, M. abscessus, and M. chelonae1-3. All are environ-
mental microorganisms found in soil, bioaerosols, and 
natural and chlorinated water1-3. RGM lung disease is 
predominantly due to M. abscessus (80% of cases) and 
M. fortuitum (15% of cases)4,5. M. chelonae usually 
causes skin, bone, and soft tissue infections and is a 
very rare respiratory pathogen6,7. Here, we report a case 
of M. chelonae lung disease associated with bronchiec-
tasis in a previously healthy woman.
Case Report
  In April 2008, a 69-year-old woman was referred to 
our hospital because of hemoptysis. She had been 
healthy until one month prior, when intermittent he-
moptysis developed. The patient had no smoking his-
tory or other medical history. On examination, the pa-
tient appeared well. Her weight was 45 kg, height 156.2 
cm, temperature 36.2oC, blood pressure 133/75 mm Hg, 
pulse 73 beats per minute, and oxygen saturation 100% 
while breathing ambient air. Laboratory results were 
normal. A human immunodeficiency virus antibody test 
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Figure 1. A 69-year-old woman with bronchiectasis and nontuberculous mycobacterial lung disease caused by 
Mycobacterium chelonae. (A) A transverse computed tomography (CT) scan (2.5-mm-section thickness) at the time of
presentation reveals bronchiectasis and bronchiolitis in the lingular division of the left upper lobe. (B) Mild bronchiectasis
was noted in the superior segment of the left lower lobe at the time of presentation. (C) A CT scan of the same patient
at 3 years after diagnosis reveals mild progression of peribronchial infiltration on the lingular division of the left upper
lobe. (D) There was newly appearing bronchiolitis in the superior segment of the left lower lobe.
was negative.
  A computed tomography (CT) scan of the chest re-
vealed bronchiectasis and bronchiolitis in the lingular 
division of the left upper lobe (Figure 1A, B). There 
was no evidence of cystic fibrosis or other common 
causes of bronchiectasis. NTM were isolated three times 
from sputum specimens.
  NTM species were identified using a polymerase 
chain reaction-restriction fragment length polymorphism 
analysis (PRA) based on the partial region of the rpoB 
gene8. Colonies were scraped, and genomic DNA of the 
isolate was extracted using a commercial kit (QIAamp 
DNA Mini kit; Qiagen, Hilden, Germany). Amplification 
of the partial rpoB gene (360 bp) was performed using 
primers Rpo5' (5'-TCAAGGAGAAGCGCTACGA-3') and 
Rpo3' (5'-GGATGTTGATCAGGGTCTGC-3')8 with sub-
sequent digestion with 5 units of Msp I (New England 
BioLabs, Beverly, MA, USA) for 3 hours at 37oC. The 
digestion mixtures were analyzed by 3% (w/v) agarose 
gel electrophoresis. DNA size markers, pBR322-MspI-di-
gested DNA (New England BioLabs) were used to en-
able estimation of DNA fragment size. The PRA results 
were determined by comparing their restriction patterns 
with those available in the National Center for Biotech-
nology Information GenBank database9 and referred to 
as described by Lee et al.8 for the rpoB-PRA. The rpoB 
amplicon restricted by MspI resulted in fragment sizes 
of 105, 95, 80, 50, and 40 bp in two serial cultures 
(Figure 2). The rpoB-PRA patterns of those cultures ex-
actly matched the known restriction fragment pattern of 
the reference strain of M. chelonae subsp. chelonae 
ATCC35749. 
  The identification of these NTM isolates was further 
confirmed by DNA sequence analysis of the partial rpoB 
gene (723 bp) using primers MycoF (5'-GGCAAGGTC-
ACCCCGAAGGG-3') and MycoR (5'-AGCGGCTGCTGG-
Tuberculosis and Respiratory Diseases Vol. 74. No. 4, Apr. 2013
193
Figure 2. Electrophoresis of the polymerase chain re-
action-restriction fragment length polymorphism analysis 
(PRA) of the rpoB gene involving digestion with MspI. 
Mycobacteria isolated from two serial specimens gen-
erated the fragments of 105, 95, 80, 50, and 40 bp, 
which were identical to those of Mycobacterium chelonae
subsp. chelonae ATCC35749. M, size marker; Lanes 1 
and 2, patterns of rpoB-PRA from two serial samples iso-
lated; Lane 3, the matched pattern of the reference strain
M. chelonae subsp. chelonae ATCC35749.
GTGATCATC-3')10 and the partial hsp65 gene (439 bp) 
using primers Tb11 (5'-ACCAACGATGGTGTGTCCAT-3') 
and Tb12 (5'-CTTGTCGAACCGCATACCCT-3'). The re-
sults revealed sequence similarity (above 99.9%) with 
M. chelonae for the rpoB gene (GenBank accession no. 
EU109300.1) and hsp65 gene (GenBank accession no. 
U55832).
  Finally, the patient was diagnosed with M. chelonae 
lung disease. Antibiotic therapy was not initiated be-
cause of her mild symptoms. Three years after diagnosis 
of M. chelonae lung disease, follow-up chest CT was 
performed. Although there was mild progression of per-
ibronchial infiltration on the lingular division of the left 
upper lobe and newly appeared bronchiolitis in the su-
perior segment of the left lower lobe (Figure 1C, D), 
she did not complain of aggravation of her symptoms. 
Discussion
  The nomenclature of RGM has changed frequently 
and has been a source of confusion for clinicians. For 
instance, within the past approximately 20 years, M. ab-
scessus, the most common RGM respiratory pathogen, 
was labeled as M. cheloneii subsp. abscessus, M. chelo-
nae subsp. abscessus, and finally, in 1992, M. ab-
scessus11. Unfortunately, some mycobacterial labo-
ratories still report M. abscessus isolates as M. chelonae 
complex or M. chelonae/abscessus group without fur-
ther species identification12,13. The species identification 
is important because therapy differs significantly de-
pending on the RGM species obtained. Because M. che-
lonae is an extremely rare cause of pulmonary disease, 
most respiratory isolates that are identified as M. chelo-
nae/abscessus complex can be reasonably assumed to 
be M. abscessus isolates2.
  Identifying RGM to the species level is very im-
portant1-3. Biochemical tests that assess phenotype char-
acteristics have commonly been used by clinical labo-
ratories to characterize RGM. However, these are 
time-consuming and do not always lead to identification 
of the organism to the species level2,3. High-perform-
ance liquid chromatography, which is a useful method 
for identifying slowly growing NTM, may not enable 
separation of M. chelonae and M. abscessus2,3. Molecu-
lar methods can provide reliable and rapid identification 
of RGM1. In this study, the M. chelonae isolates were 
identified using rpoB gene based-PRA and sequence 
analysis of the rpoB and hsp65 genes.
  Skin, bone, and soft tissue disease are the most im-
portant clinical manifestations of M. chelonae infection. 
Disseminated M. chelonae infection can also occur in 
immunocompromised patients1. M. chelonae is an in-
creasingly recognized cause of keratitis, especially after 
injury with a foreign body or following office oph-
thalmologic procedures1. However, M. chelonae is a 
much less frequent cause of lung disease than M. ab-
scessus1-3.
  Reported cases of M. chelonae lung disease are usu-
ally middle-aged or elderly women with no other co-ex-
isting parenchymal lung disease. The symptoms and ra-
diographic presentation of M. chelonae lung disease are 
similar to those of other RGM lung diseases5. Bronchiec-
tasis, nodules, and consolidation are the most common 
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CT features14.
  It is important to distinguish M. chelonae from M. ab-
scessus because therapy for M. chelonae is potentially 
easier than for M. abscessus infection1. M. chelonae is 
resistant to anti-tuberculosis agents but is susceptible to 
a number of traditional anti-bacterial agents such as to-
bramycin (100%), clarithromycin (100%), linezolid 
(90%), imipenem (60%), amikacin (50%), clofazimine, 
doxycycline (25%), and ciprofloxacin (20%)1. In addi-
tion, inducible resistance to clarithromycin which is con-
ferred by an erm (41) gene is found in M. abscessus 
but is absent from M. chelonae15.
  In conclusion, M. chelonae should be considered a 
possible etiologic pathogen of the nodular bronchiec-
tatic form of NTM lung disease, despite the rarity of pul-
monary M. chelonae infection. To the best of our 
knowledge, this is the first documented case of M. che-
lonae lung disease in an immunocompetent adult in 
Korea in which the etiologic organism was confirmed 
using molecular methods that characterized rpoB and 
hsp65 gene sequences.
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